Theodoros Kontoulis: Heterogeneity of residual disease (RD) after NACT in breast cancer

Theodoros Kontoulis shared on LinkedIn:

“Most viewed in the last 7 days from JAMA Oncology: This Review analyzes the heterogeneity of residual disease (RD) after NACT in breast cancer.

Uncovering the anatomic and biological intricacies of RD will allow for increased precision in postneoadjuvant treatments, moving beyond the binary paradigm of RD vs pCR, toward more tailored adjuvant therapies.”

Source: Theodoros Kontoulis/LinkedIn

Theodoros Kontoulis is a Consultant Oncoplastic Breast Surgeon at Genesis Obstetrics Gynecology Surgery Hospital and St. Luke’s Hospital Thessaloniki. Previously, he was a Locum Consultant Breast Surgeon at Guy’s and St Thomas’ NHS Foundation Trust.